propionylcarnitine has been researched along with Intermittent Claudication in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (55.00) | 18.2507 |
| 2000's | 7 (35.00) | 29.6817 |
| 2010's | 2 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Jin, B; Li, J; Li, K; Li, L; Liu, C; Luo, T; Yang, B; Zhang, J; Zhang, X; Zheng, Q | 1 |
| Andreozzi, GM | 1 |
| Amato, A; Brass, EP; Hiatt, WR; Koster, D | 1 |
| Hiatt, WR | 2 |
| Izzo, A; Koverech, A; Liguori, M; Messano, M; Palermo, G; Riccioni, C; Sarcinella, R; Virmani, A | 1 |
| Brevetti, G; Condorelli, M; Martone, VD; Perna, S; Sabbá, C | 1 |
| Corsi, C; D'Iddio, S; Giordano, S; Leanza, D; Marrapodi, E; Pollastri, M | 1 |
| Barletta, G; Brevetti, G; Di Iorio, A; Martone, VD; Perna, S; Sabba, C | 1 |
| Deckert, J | 1 |
| Capecchi, PL; Di Perri, T; Laghi Pasini, F; Quartarolo, E | 1 |
| Amato, A; Hands, LJ; Kemp, GJ; Nicolaides, A; Radda, GK; Ramaswami, G; Taylor, DJ | 1 |
| Brevetti, G; Corrado, S; Di Donato, AM; Di Iorio, A; Martone, VD; Silvestro, A | 1 |
| Dal Lago, A; De Martini, D; Flore, R; Gaetani, E; Gasbarrini, A; Gerardino, L; Nolfe, G; Pola, R; Santoliquido, A; Serricchio, M; Tondi, P | 1 |
| Brevetti, G; Diehm, C; Lambert, D | 1 |
| Amato, A; Cooke, JP; Creager, MA; Gorbunov, GN; Hiatt, WR; Hirsch, AT; Isner, J; Lukjanov, YV; Olin, JW; Regensteiner, JG; Tsitsiashvili, MS; Zabelskaya, TF | 1 |
| Askew, CD; Barker, GA; Green, AA; Green, S; Walker, PJ | 1 |
| Doggrell, SA | 1 |
| Berardi, E; Brevetti, G; Godi, L; Perna, S; Rossini, A; Sabbà, C; Scotto di Uccio, V | 1 |
| Coto, V; D'Alessandro, L; Grattarola, G; Imparato, L; Lingetti, M; Mancini, M; Nolfe, G; Rengo, F | 1 |
5 review(s) available for propionylcarnitine and Intermittent Claudication
| Article | Year |
|---|---|
Propionyl l-carnitine: intermittent claudication and peripheral arterial disease.
Topics: Cardiotonic Agents; Carnitine; Exercise; Humans; Intermittent Claudication; Peripheral Vascular Diseases | 2009 |
A systematic review and meta-analysis of propionyl-L-carnitine effects on exercise performance in patients with claudication.
Topics: Carnitine; Clinical Trials as Topic; Exercise Test; Humans; Intermittent Claudication; Walking | 2013 |
Carnitine and peripheral arterial disease.
Topics: Arterial Occlusive Diseases; Carnitine; Humans; Intermittent Claudication; Muscle, Skeletal; Oxygen Consumption | 2004 |
New treatment options in intermittent claudication: the US experience.
Topics: Arginine; Carnitine; Cilostazol; Endothelial Growth Factors; Exercise Therapy; Humans; Intermittent Claudication; Multicenter Studies as Topic; Nafronyl; Pentoxifylline; Phosphodiesterase Inhibitors; Prostaglandins; Quality of Life; Randomized Controlled Trials as Topic; Serotonin Antagonists; Tetrazoles; United States | 2001 |
Pharmacotherapy of intermittent claudication.
Topics: Animals; Anticoagulants; Cardiotonic Agents; Carnitine; Cilostazol; Humans; Intermittent Claudication; Nafronyl; Nitric Oxide; Pentoxifylline; Platelet Aggregation Inhibitors; Tetrazoles; Vasodilator Agents | 2001 |
13 trial(s) available for propionylcarnitine and Intermittent Claudication
| Article | Year |
|---|---|
A study on the efficacy and safety assessment of propionyl-L-carnitine tablets in treatment of intermittent claudication.
Topics: Administration, Oral; Aged; Carnitine; Double-Blind Method; Humans; Intermittent Claudication; Middle Aged; Pentoxifylline; Peripheral Arterial Disease; Treatment Outcome; Walking | 2013 |
Evaluation of the efficacy of propionyl-L-carnitine versus pulsed muscular compressions in diabetic and non-diabetic patients affected by obliterating arteriopathy Leriche stage II.
Topics: Aged; Arterial Occlusive Diseases; Cardiovascular Agents; Carnitine; Combined Modality Therapy; Diabetes Mellitus, Type 2; Female; Humans; Infusions, Intravenous; Intermittent Claudication; Intermittent Pneumatic Compression Devices; Male; Middle Aged; Quality of Life; Recovery of Function; Severity of Illness Index; Time Factors; Treatment Outcome; Walking | 2008 |
Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study.
Topics: Administration, Oral; Analysis of Variance; Cardiotonic Agents; Carnitine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Intermittent Claudication; Male; Middle Aged; Treatment Outcome | 1995 |
L-propionylcarnitine effect on postexercise and postischemic hyperemia in patients affected by peripheral vascular disease.
Topics: Aged; Blood Flow Velocity; Carnitine; Cross-Over Studies; Double-Blind Method; Humans; Hyperemia; Injections, Intravenous; Intermittent Claudication; Ischemia; Leg; Male; Middle Aged; Physical Exertion | 1995 |
Effect of propionyl-L-carnitine on quality of life in intermittent claudication.
Topics: Aged; Cardiotonic Agents; Carnitine; Double-Blind Method; Female; Humans; Intermittent Claudication; Italy; Male; Middle Aged; Quality of Life; Surveys and Questionnaires; Time Factors; Walking | 1997 |
Propionyl-L-carnitine for intermittent claudication.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Attitude to Health; Carnitine; Double-Blind Method; Emotions; Exercise Test; Female; Follow-Up Studies; Humans; Intermittent Claudication; Male; Placebos; Quality of Life; Walking | 1997 |
Changes in energy metabolism of calf muscle in patients with intermittent claudication assessed by 31P magnetic resonance spectroscopy: a phase II open study.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adult; Aged; Aged, 80 and over; Carnitine; Energy Metabolism; Female; Humans; Intermittent Claudication; Leg; Magnetic Resonance Spectroscopy; Male; Middle Aged; Muscle, Skeletal; Phosphocreatine; Phosphorus; Walking | 1996 |
Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trial.
Topics: Adult; Aged; Arterial Occlusive Diseases; Cardiotonic Agents; Carnitine; Double-Blind Method; Exercise Test; Female; Humans; Intermittent Claudication; Leg; Male; Middle Aged; Placebos | 1999 |
European multicenter study on propionyl-L-carnitine in intermittent claudication.
Topics: Cardiotonic Agents; Carnitine; Double-Blind Method; Europe; Female; Humans; Intermittent Claudication; Male; Middle Aged; Prospective Studies; Quality of Life; Treatment Outcome | 1999 |
Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Carnitine; Double-Blind Method; Exercise Tolerance; Female; Humans; Intermittent Claudication; Male; Middle Aged | 2001 |
Effect of propionyl-L-carnitine on exercise performance in peripheral arterial disease.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Carnitine; Exercise; Female; Humans; Intermittent Claudication; Male; Middle Aged; Muscle, Skeletal; Peripheral Vascular Diseases; Physical Endurance; Single-Blind Method; Treatment Outcome; Walking | 2001 |
Superiority of L-propionylcarnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease: an acute, intravenous, double-blind, cross-over study.
Topics: Arterial Occlusive Diseases; Carnitine; Dose-Response Relationship, Drug; Double-Blind Method; Exercise Test; Hemodynamics; Humans; Infusions, Intravenous; Intermittent Claudication; Ischemia; Leg; Male; Middle Aged | 1992 |
Evaluation of the therapeutic efficacy and tolerability of levocarnitine propionyl in the treatment of chronic obstructive arteriopathies of the lower extremities: a multicentre controlled study vs. placebo.
Topics: Administration, Oral; Aged; Analysis of Variance; Arterial Occlusive Diseases; Arteriosclerosis; Carnitine; Diabetic Angiopathies; Female; Humans; Intermittent Claudication; Male; Middle Aged; Patient Compliance; Regression Analysis; Stereoisomerism | 1992 |
2 other study(ies) available for propionylcarnitine and Intermittent Claudication
| Article | Year |
|---|---|
Carnitines increase plasma levels of adenosine and ATP in humans.
Topics: Acetylcarnitine; Adenosine; Adenosine Triphosphate; Aged; Analysis of Variance; Cardiotonic Agents; Carnitine; Female; Humans; Infusions, Intravenous; Inosine; Intermittent Claudication; Male | 1997 |
[A new therapeutic proposal for intermittent claudication. Propionyl-L-carnitine: new indications concerning mechanism of action].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Viscosity; Cardiotonic Agents; Carnitine; Energy Metabolism; Humans; Intermittent Claudication; Microcirculation; Multicenter Studies as Topic; Rats | 1998 |